Pay in 4 interest-free payments of $6.74 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Your body may still be adapting, and premature increases can lead to unnecessary side effects
Clinical trials have demonstrated that tirzepatide can reduce hemoglobin A1c by up to 2.5% in type 2 diabetes, with weight loss typically ranging from 5-10% in diabetes patients and 15-20% in those treated specifically for obesity
No other GLP-1 medication has produced comparable liver results
PlexusDx makes this therapy accessible through compounded semaglutide injections at $189/mo month-to-month, or from $149/mo on the 6-month plan, tailored to your body's unique needs
US$ 26.44
US$ 24.14
US$ 28.85
US$ 25.34
US$ 26.98
US$ 21.65
US$ 23.64
